🔎 Trials Near Me

Domov › Debelost › Missouri

Klinične študije za Debelost v Missouri

54 študij za Debelost išče udeležence na lokacijah v Missouri.

Mesta v Missouri

Uradno besedilo študije (angleško)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Studymetrix Research /ID# 282163, City of Saint Peters
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07752979

Effects of Pistachios on Postprandial Metabolic Responses in Adults With Overweight or Obesity

  • Saint Louis University, St Louis
Vključevanje udeležencev
Starost 18–35 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07853898

Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study

  • Saint Louis University, St Louis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–35 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07849439

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • StudyMetrix Research LLC, City of Saint Peters
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Amicis Centers of Clinical Research, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07668414

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Kansas City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07776509

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Sundance Clinical Research, St Louis
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • StudyMetrix Research LLC, City of Saint Peters
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Clinical Research Professionals, Chesterfield
  • Clinvest Headlands Llc, Springfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Clinical Research Professionals, Chesterfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Clayton Sleep Institute - St. Louis - Tesson Ferry Road, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • StudyMetrix Research, City of Saint Peters
  • Alliance for Multispecialty Research - Kansas City, Kansas City
  • Kansas City Veterans Affairs Medical Center, Kansas City
  • in še 1
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • StudyMetrix Research, City of Saint Peters
  • Clinvest Headlands Llc, Springfield
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Columbia
  • AURORA-2 Clinical Site, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Saint Luke's Hospital of Kansas City, Kansas City
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Kansas City VA Medical Center, Kansas City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Clinvest Research LLC, Springfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Springfield
Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci
Starost 25–75 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07815678

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Chesterfield
  • ACCOMPLISH-2 Research Site, City of Saint Peters
  • ACCOMPLISH-2 Research Site, Hazelwood
  • in še 2
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
Starost 18–79 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • StudyMetrix Research LLC, City of Saint Peters
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • StudyMetrix Research, City of Saint Peters
  • Clinvest Headlands Llc, Springfield
Vključevanje udeležencevFaza 2
Starost 18–75 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Alliance for Multispecialty Research - Kansas City, Kansas City
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Alliance for Multispecialty Research - Kansas City, Kansas City
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684144

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Jefferson City
  • Research Site, Kansas City
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Clinical Research Consultants, JCCT Co, Kansas City
  • Washington University, St Louis
  • Amicis Centers of Clinical Research, St Louis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Digital InteGrated Behavioral treatmeNt for Comorbid obesITy and deprEssion Among Racial and Ethnic Adults Age 50 and Older

  • Washington University School of Medicine in St Louis, St Louis
Vključevanje udeležencev
Starost 50–74 · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT06636058

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  • Clinvest Research, Springfield
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT07509307

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Chesterfield
  • ACCOMPLISH-1 Research Site, Hazelwood
  • ACCOMPLISH-1 Research Site, St Louis
Vključevanje udeležencevFaza 3
Starost 18–79 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07654361

Advancing Biopsychosocial Care Training Initiative

  • Washington University School of Medicine, St Louis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 5 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT07049861

Role of KATP Channel Loss in Type 2 Diabetes

  • Washington University in St. Louis, St Louis
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–65 · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06830096

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity

  • University of Missouri School of Medicine, Columbia
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06335771

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

  • University of Missouri School of Medicine, Columbia
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–70 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06571474

Routine Validation and Reproducibility Testing of Laboratory Measures and Research Techniques Used for Metabolism Research (VAL)

  • University of Missouri School of Medicine, Columbia
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 18–75 · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT06286761

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

  • University of Missouri-Columbia, Columbia
Vključevanje udeležencev
Starost 18–60 · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT07231484

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

  • University of Missouri, Columbia
Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci
Starost 18–45 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT05219799

Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care Clinics

  • Washington University in St. Louis, St Louis
Vključevanje udeležencev
Starost 18–64 · Vsi spoli · Posodobljeno 17. jul. 2026 · NCT06397729

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.